バイオジェン株式会社
MX ˙ BMV ˙ US09062X1037
SecurityMX:BIIB / Biogen Inc.
InstitutionWalleye Capital LLC
Latest Disclosed Ownership35,339 shares
Latest Disclosed Value $ 6,478,699
Walleye Capital LLC ownership in BIIB / Biogen Inc.

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 35,339 shares of Biogen Inc. (MX:BIIB) valued at $6,478,699 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,575 shares of Biogen Inc.. This represents a change in shares of 2,143.75% during the quarter.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (BIIB) in the form of stock options. The firm currently holds call options representing 13,600 of underlying shares valued at $2,493,288 USD and put options representing 18,700 of underlying shares valued at $3,428,271 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:BIIB / Biogen Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 BIOGEN COM 09062X103 35,339 33,764 2,143.75 6,479 2,238.63 0.0270
2026-05-08 2026-03-31 13F BIOGEN COM 09062X103 35,339 33,764 6,479 0.0269
2026-02-13 2025-12-31 13F BIOGEN COM 09062X103 1,575 -62 -3.79 277 20.96 0.0009
2025-11-14 2025-09-30 13F BIOGEN COM 09062X103 1,637 -2,318 -58.61 229 -53.83 0.0009
2025-08-13 2025-06-30 13F BIOGEN COM 09062X103 3,955 -65,950 -94.34 497 -94.81 0.0019
2025-05-14 2025-03-31 13F BIOGEN COM 09062X103 69,905 59,865 596.26 9,566 523.13 0.0432
2025-02-13 2024-12-31 13F BIOGEN COM 09062X103 10,040 5,387 115.77 1,535 70.37 0.0038
2024-11-14 2024-09-30 13F BIOGEN COM 09062X103 4,653 -42,642 -90.16 902 -91.78 0.0019
2024-08-14 2024-06-30 13F BIOGEN COM 09062X103 47,295 37,711 393.48 10,964 430.64 0.0196
2024-05-15 2024-03-31 13F BIOGEN COM 09062X103 9,584 9,584 2,067 0.0037
2024-02-14 2023-12-31 13F BIOGEN COM 09062X103 0 -1,438 -100.00 0 -100.00
2023-11-21 2023-09-30 13F/A-1 BIOGEN COM 09062X103 1,438 -13,250 -90.21 370 -91.18 0.0009
2023-11-14 2023-09-30 13F BIOGEN COM 09062X103 1,438 -13,250 370 0.0010
2023-08-14 2023-06-30 13F BIOGEN COM 09062X103 14,688 994 7.26 4,184 9.88 0.0152
2023-05-15 2023-03-31 13F BIOGEN COM 09062X103 13,694 -20,803 -60.30 3,807 -60.14 0.0570
2023-02-14 2022-12-31 13F BIOGEN COM 09062X103 34,497 34,497 9,553 0.1742
2022-08-19 2022-06-30 13F/A-1 BIOGEN COM 09062X103 0 -1,685 -100.00 0 -100.00
2022-08-08 2022-06-30 13F BIOGEN COM 09062X103 0 -1,685 0
2022-05-27 2022-03-31 13F/A-01 BIOGEN COM 09062X103 1,685 1,685 355 0.0095
2022-05-16 2022-03-31 13F BIOGEN COM 09062X103 1,685 1,685 355 0.0072
2020-08-14 2020-06-30 13F BIOGEN COM 09062X103 0 -180 -100.00 0 -100.00
2020-05-15 2020-03-31 13F BIOGEN COM 09062X103 180 -30 -14.29 57 -8.06 0.0125
2020-02-14 2019-12-31 13F BIOGEN COM 09062X103 210 -3,342 -94.09 62 -92.50 0.0040
2019-11-14 2019-09-30 13F BIOGEN COM 09062X103 3,552 3,392 2,120.00 827 2,135.14 0.0493
2019-08-14 2019-06-30 13F BIOGEN COM 09062X103 160 160 37 0.0041
2019-08-14 2019-03-31 13F/A-1 BIOGEN COM 09062X103 0 -1,591 -100.00 0 -100.00
2018-11-14 2018-09-30 13F BIOGEN COM 09062X103 1,591 1,591 562 0.2623
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A BIOGEN COM Call 13,600 -69.71 2,493 -68.45 n/a n/a n/a
2026-05-08 2026-03-31 13F BIOGEN COM Call 13,600 2,493 n/a n/a n/a
2026-02-13 2025-12-31 13F BIOGEN COM Call 44,900 162.57 7,902 229.90 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOGEN COM Call 17,100 -43.56 2,395 -37.06 n/a n/a n/a
2025-08-13 2025-06-30 13F BIOGEN COM Call 30,300 -0.33 3,805 -8.51 n/a n/a n/a
2025-05-14 2025-03-31 13F BIOGEN COM Call 30,400 316.44 4,160 272.67 n/a n/a n/a
2025-02-13 2024-12-31 13F BIOGEN COM Call 7,300 14.06 1,116 -10.00 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOGEN COM Call 6,400 -65.78 1,241 -71.40 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOGEN COM Call 18,700 -71.58 4,335 -69.45 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOGEN COM Call 65,800 341.61 14,188 268.04 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOGEN COM Call 14,900 63.74 3,856 64.88 n/a n/a n/a
2023-11-21 2023-09-30 13F/A BIOGEN COM Call 9,100 127.50 2,339 105.27 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOGEN COM Call 9,100 2,339 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOGEN COM Call 4,000 8.11 1,139 10.80 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOGEN COM Call 3,700 60.87 1,029 61.64 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOGEN COM Call 2,300 637 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOGEN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOGEN COM Call 900 -90.11 285 -89.44 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOGEN COM Call 9,100 -69.15 2,700 -60.69 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOGEN COM Call 29,500 85.53 6,868 84.67 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOGEN COM Call 15,900 1,490.00 3,719 1,475.85 n/a n/a n/a
2019-08-14 2019-03-31 13F/A BIOGEN COM Call 1,000 236 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOGEN COM Call 1,000 236 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A BIOGEN COM Put 18,700 -62.60 3,428 -61.04 n/a n/a n/a
2026-05-08 2026-03-31 13F BIOGEN COM Put 18,700 3,428 n/a n/a n/a
2026-02-13 2025-12-31 13F BIOGEN COM Put 50,000 96.85 8,800 147.30 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOGEN COM Put 25,400 13.90 3,558 27.07 n/a n/a n/a
2025-08-13 2025-06-30 13F BIOGEN COM Put 22,300 -52.55 2,801 -56.46 n/a n/a n/a
2025-05-14 2025-03-31 13F BIOGEN COM Put 47,000 215.44 6,431 182.31 n/a n/a n/a
2025-02-13 2024-12-31 13F BIOGEN COM Put 14,900 3.47 2,279 -18.38 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOGEN COM Put 14,400 -70.25 2,791 -75.12 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOGEN COM Put 48,400 -5.47 11,220 1.63 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOGEN COM Put 51,200 11.30 11,040 -7.25 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOGEN COM Put 46,000 27.78 11,903 28.65 n/a n/a n/a
2023-11-21 2023-09-30 13F/A BIOGEN COM Put 36,000 -5.01 9,252 -14.29 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOGEN COM Put 36,000 9,252 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOGEN COM Put 37,900 2,607.14 10,796 2,675.06 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOGEN COM Put 1,400 -22.22 389 -21.89 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOGEN COM Put 1,800 498 n/a n/a n/a
2020-05-15 2020-03-31 13F BIOGEN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOGEN COM Put 18,100 -33.46 5,371 -15.19 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOGEN COM Put 27,200 253.25 6,333 251.64 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOGEN COM Put 7,700 1,801 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.